Time filter

Source Type

Clamart, France

Pham T.,Marseille University Hospital Center | Bachelez H.,CHU Saint Louis | Berthelot J.-M.,Nantes University Hospital Center | Blacher J.,CHU Hotel Dieu | And 32 more authors.
Joint Bone Spine

Objectives: To develop and/or update fact sheets about TNFα antagonists treatments, in order to assist physicians in the management of patients with inflammatory joint disease. Methods: selection by a committee of rheumatology experts of the main topics of interest for which fact sheets were desirable;. Identification and review of publications relevant to each topic;. Development and/or update of fact sheets based on three levels of evidence: evidence-based medicine, official recommendations, and expert opinion. The experts were rheumatologists and invited specialists in other fields, and they had extensive experience with the management of chronic inflammatory diseases, such as rheumatoid. They were members of the CRI (Club Rhumatismes et Inflammation), a section of the Société Francaise de Rhumatologie. Each fact sheet was revised by several experts and the overall process was coordinated by three experts. Results: Several topics of major interest were selected: contraindications of TNFα antagonists treatments, the management of adverse effects and concomitant diseases that may develop during these therapies, and the management of everyday situations such as pregnancy, surgery, and immunizations. After a review of the literature and discussions among experts, a consensus was developed about the content of the fact sheets presented here. These fact sheets focus on several points: In RA and SpA, initiation and monitoring of TNFα antagonists treatments, management of patients with specific past histories, and specific clinical situations such as pregnancy;. Diseases other than RA, such as juvenile idiopathic arthritis. Models of letters for informing the rheumatologist and general practitioner;4.and patient information. Conclusion: These TNFα antagonists treatments fact sheets built on evidence-based medicine and expert opinion will serve as a practical tool for assisting physicians who manage patients on these therapies. They will be available continuously at www.cri-net.com and updated at appropriate intervals. © 2011 Elsevier Masson SAS. Source

Discover hidden collaborations